The global demand for Radiotherapy Device Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of 6.7% under the study period 2023 - 2030.
Radiotherapy devices, also known as radiation therapy devices, are medical equipment used to deliver high-energy radiation to cancerous cells in the body to destroy or shrink them. The radiation may be delivered externally or internally, depending on the cancer type and its location.
Market Dynamics
The global incidence of cancer is witnessing a notable rise, as projected by the World Health Organization, which anticipates nearly 30 million new cases of cancer each year by 2040. Radiotherapy devices play a crucial role in the treatment of cancer. This technology is advancing rapidly, with new devices offering greater precision, higher dose rates, and reduced treatment times. These advancements are improving treatment outcomes and reducing side effects, making this therapy a more attractive treatment option. Many countries have favourable reimbursement policies, which have increased patient access to radiotherapy and stimulated market growth. IGRT uses imaging techniques such as CT, MRI, or PET to guide the delivery of radiation to the tumour site. IGRT allows for more accurate delivery of radiation, minimising exposure to healthy tissue and reducing side effects. Proton therapy, a form of radiotherapy employing protons rather than X-rays, is employed to administer radiation to cancer cells. It demonstrates particular effectiveness in treating tumours located in sensitive areas, like the brain or spinal cord. The demand for proton therapy is escalating, leading to the establishment of new facilities worldwide.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of radiotherapy device. The growth and trends of radiotherapy device industry provide a holistic approach to this study.
Market Segmentation
This section of the radiotherapy device market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- External Beam
- Internal Beam
By Application
- Hospitals
- Ambulatory Surgical Centres
- Oncological Treatment Centres
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Radiotherapy Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Radiotherapy Device Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the radiotherapy device market include Varian Medical Systems, Elekta AB, Accuray, Inc., C.R. Bard, Inc., IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens AG, Eckert & Ziegler Bebig, IsoRay, Inc., GE Healthcare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corp, Toshiba Medical Systems Corporation, AngioDynamics, Inc., Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, Neusoft Medical Systems Co., Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.